BioSpace News Archive

Business

Children’s Hospitals and Pediatric Congenital Heart Association Call for Transparency In Cardiac Surgical Outcomes

Children’s Hospital Colorado and others are partnering with the Pediatric Congenital Heart Association (PCHA) in an effort to make this information more accessible and understandable to families impacted by CHD.

October 14, 2019
·
4 min read
Drug Development

Reata Announces Positive Topline Results from the MOXIe Registrational Trial of Omaveloxolone in Patients with Friedreich’s Ataxia

ACHIEVED PRIMARY ENDPOINT OF STATISTICALLY SIGNIFICANT IMPROVEMENT IN MFARS COMPARED TO PLACEBO AFTER 48 WEEKS OF TREATMENT

October 14, 2019
·
9 min read
BioCapital

QIAGEN Launches New QIAseq FastSelect Solutions to Accelerate RNA-seq

Highlighting broad portfolio of universal NGS solutions at American Society for Human Genetics (ASHG) 2019 genomic research conference

October 14, 2019
·
1 min read
Business

NuVasive Announces Conference Call and Webcast of Third Quarter 2019 Results

The Company will release its third quarter 2019 earnings results on Wednesday, October 30, 2019 after the close of the market.

October 14, 2019
·
2 min read
Business

Senseonics Announces a Positive Coverage Decision for Eversense CGM from Health Care Service Corporation - Blue Cross Blue Shield of Illinois, Montana, New Mexico, Oklahoma and Texas

HCSC coverage decision adds more than 16 million covered lives for Eversense CGM

October 14, 2019
·
5 min read
FDA

Akorn Receives FDA Approval for Betamethasone Dipropionate Lotion USP (Augmented), 0.05%

The product is manufactured at Akorn’s Amityville, New York manufacturing facility.

October 14, 2019
·
1 min read
Pharm Country

Redesign Science Raises $2M in Seed Funding to Advance Early-Stage Drug Discovery

Investment to support scaling of technology platform and advance multiple biotech partnerships

October 14, 2019
·
2 min read
Drug Development

Forbius Completes Enrollment into Phase 1a Solid Tumor Trial of AVID200, First-in-Class TGF-beta 1 & 3 Inhibitor; Closes Series C Financing

AVID200 is a first-in-class, selective inhibitor of TGF-beta 1 & 3, the main pathogenic TGF-beta isoforms; AVID200 spares TGF-beta 2 for optimal safety

October 14, 2019
·
3 min read
Pharm Country

Nephros, Inc. (Nasdaq: NEPH) to Ring The Nasdaq Stock Market Closing Bell

Nephros, Inc. (Nasdaq: NEPH), a commercial stage company that develops and sells high performance water purification products to the medical device and commercial markets, will visit the Nasdaq MarketSite in Times Square

October 14, 2019
·
2 min read
Business

Apyx Medical Corporation Announces Subject Enrollment Initiated in Study Evaluating the Use of Renuvion® Technology in Skin Laxity Procedures in the Neck and Submental Region

Apyx Medical Corporation, formerly Bovie Medical Corporation, (NASDAQ:APYX) (the “Company”), a maker of medical devices and supplies and the developer of its Helium Plasma Technology, marketed and sold as Renuvion®

October 14, 2019
·
4 min read